Congenital Transmission of Lineages I and II of Trypanosoma Cruzi

计划入组 28,348 人 · 首次发布于 2013 年 2 月 11 日

Prospective Evaluation of Rapid Diagnostic Tests for Trypanosoma Cruzi Infection

计划入组 3,234 人 · 首次发布于 2025 年 12 月 26 日

Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age

计划入组 87 人 · 首次发布于 2018 年 9 月 14 日

NPD-0142

Nifurtimox(Lampit)

C₁₀H₁₃N₃O₅S

Fexinidazole

C₁₂H₁₃N₃O₃S

FUNDACAO OSWALDO CRUZ

Brazil

Fundação Oswaldo Cruz

Brazil

HOSPITAL ALEMAO OSWALDO CRUZ

Brazil

AN2 Therapeutics Partners with DNDi to Advance Oral Chagas Disease Treatment AN2-502998

Sacubitril/Valsartan Shows Superior Efficacy Over Enalapril in First Prospective Trial for Chagas Disease Heart Failure

CDC Officially Recognizes Chagas Disease as Endemic in the United States, With an Estimated 300,000 Americans Affected